{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:44:15Z","timestamp":1771062255958,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T00:00:00Z","timestamp":1423008000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12883-015-0266-8","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T05:20:34Z","timestamp":1422940834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multicentric Castleman\u2019s disease with voltage-gated potassium channel antibody-positive limbic encephalitis: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Vikram R","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leland E","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Fong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina I","family":"Garga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L","family":"Parko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,4]]},"reference":[{"issue":"23","key":"266_CR1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM195406102502308","volume":"250","author":"B Castleman","year":"1954","unstructured":"Castleman B, Towne VW. Case records of the Massachusetts general hospital: case No. 40231. N Engl J Med. 1954;250(23):1001\u20135.","journal-title":"N Engl J Med"},{"issue":"9","key":"266_CR2","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S1470-2045(14)70319-5","volume":"15","author":"F Rhee van","year":"2014","unstructured":"van Rhee F, Wong RS, Munshi N, Rossi JF, Ke XY, Fossa A, et al. Siltuximab for multicentric Castleman's disease: a randomised, double-blind. Placebo-Controlled Trial Lancet Oncol. 2014;15(9):966\u201374.","journal-title":"Placebo-Controlled Trial Lancet Oncol"},{"issue":"5","key":"266_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000069821","volume":"38","author":"A Sotrel","year":"2003","unstructured":"Sotrel A, Castellano-Sanchez AA, Prusmack C, Birchansky S, Brathwaite C, Ragheb J. Castleman's disease in a child presenting with a partly mineralized solitary meningeal mass. Pediatr Neurosurg. 2003;38(5):232\u20137.","journal-title":"Pediatr Neurosurg"},{"issue":"1","key":"266_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2176\/nmc.45.59","volume":"45","author":"K Matsumura","year":"2005","unstructured":"Matsumura K, Nakasu S, Tanaka T, Nioka H, Matsuda M. Intracranial localized Castleman's disease. Case report. Neurol Med Chir (Tokyo). 2005;45(1):59\u201365.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"1","key":"266_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/BOR.0b013e32834db525","volume":"24","author":"TW Muskardin","year":"2012","unstructured":"Muskardin TW, Peterson BA, Molitor JA. Castleman disease and associated autoimmune disease. Curr Opin Rheumatol. 2012;24(1):76\u201383.","journal-title":"Curr Opin Rheumatol"},{"key":"266_CR6","doi-asserted-by":"publisher","first-page":"P1.027","DOI":"10.1212\/WNL.0000000000000152","volume":"82","author":"S Lee","year":"2014","unstructured":"Lee S, Le S. Paraneoplastic cerebellar degeneration with castleman disease: a case report. Neurology. 2014;82:P1.027.","journal-title":"Neurology"},{"issue":"2","key":"266_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000351835","volume":"6","author":"M Alcantara","year":"2013","unstructured":"Alcantara M, Bennani O, Verdure P, Lepretre S, Tilly H, Jardin F. Voltage-gated potassium channel antibody paraneoplastic limbic encephalitis associated with acute myeloid leukemia. Case Rep Oncol. 2013;6(2):289\u201392.","journal-title":"Case Rep Oncol"},{"issue":"21","key":"266_CR8","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1182\/blood-2014-03-537506","volume":"123","author":"F Graus","year":"2014","unstructured":"Graus F, Arino H, Dalmau J. Paraneoplastic neurological syndromes in Hodgkin and Non-Hodgkin lymphomas. Blood. 2014;123(21):3230\u20138.","journal-title":"Blood"},{"issue":"7","key":"266_CR9","first-page":"486","volume":"8","author":"F Rhee van","year":"2010","unstructured":"van Rhee F, Stone K, Szmania S, Barlogie B, Singh Z. Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy. Clin Adv Hematol Oncol. 2010;8(7):486\u201398.","journal-title":"Clin Adv Hematol Oncol"},{"issue":"4","key":"266_CR10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/107327481402100403","volume":"21","author":"JD Soumerai","year":"2014","unstructured":"Soumerai JD, Sohani AR, Abramson JS. Diagnosis and management of castleman disease. Cancer Control. 2014;21(4):266\u201378.","journal-title":"Cancer Control"},{"issue":"19","key":"266_CR11","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1182\/blood-2013-12-545087","volume":"123","author":"DC Fajgenbaum","year":"2014","unstructured":"Fajgenbaum DC, van Rhee F, Nabel CS. Hhv-8-negative, idiopathic multicentric castleman disease: novel insights into biology, pathogenesis, and therapy. Blood. 2014;123(19):2924\u201333.","journal-title":"Blood"},{"issue":"2","key":"266_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.24200","volume":"76","author":"SR Irani","year":"2014","unstructured":"Irani SR, Gelfand JM, Al-Diwani A, Vincent A. Cell-Surface Central Nervous System Autoantibodies: Clinical Relevance and Emerging Paradigms. Ann Neurol. 2014;76(2):168\u201384.","journal-title":"Ann Neurol"},{"issue":"8","key":"266_CR13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","volume":"10","author":"A Vincent","year":"2011","unstructured":"Vincent A, Bien CG, Irani SR, Waters P. Autoantibodies associated with diseases of the Cns: New developments and future challenges. Lancet Neurol. 2011;10(8):759\u201372.","journal-title":"Lancet Neurol"},{"issue":"5","key":"266_CR14","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/ana.22307","volume":"69","author":"SR Irani","year":"2011","unstructured":"Irani SR, Michell AW, Lang B, Pettingill P, Waters P, Johnson MR, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol. 2011;69(5):892\u2013900.","journal-title":"Ann Neurol"},{"issue":"20","key":"266_CR15","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1212\/01.wnl.0000312275.04260.a0","volume":"70","author":"KM Tan","year":"2008","unstructured":"Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology. 2008;70(20):1883\u201390.","journal-title":"Neurology"},{"issue":"Pt 3","key":"266_CR16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","volume":"127","author":"A Vincent","year":"2004","unstructured":"Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127(Pt 3):701\u201312.","journal-title":"Brain"},{"issue":"9","key":"266_CR17","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1634\/theoncologist.2011-0075","volume":"16","author":"N Talat","year":"2011","unstructured":"Talat N, Schulte KM. Castleman's disease: systematic analysis of 416 patients from the literature. Oncologist. 2011;16(9):1316\u201324.","journal-title":"Oncologist"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-015-0266-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0266-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0266-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0266-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T07:44:20Z","timestamp":1551167060000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-015-0266-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,4]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["266"],"URL":"https:\/\/doi.org\/10.1186\/s12883-015-0266-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,4]]},"assertion":[{"value":"12 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"4"}}